Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID (ACTIV-2/A5401)) - Astrazeneca

Administered By

Awarded By

Contributors

Start/End

  • March 23, 2021 - March 22, 2023